TELA Bio: regains Nasdaq minimum bid price compliance

What happened TELA Bio filed an 8-K on Oct 6, 2026 reporting that on Oct 5, 2026 the Company received a letter from The Nasdaq Stock Market LLC stating that the Company has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1). The filing says the matter is now closed and the Company’s common stock continues to be listed and traded on the Nasdaq Global Market under the trading symbol "TELA".

Key details

• Letter received from The Nasdaq Stock Market LLC on Oct 5, 2026.
• Regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1).
• Nasdaq stated the matter is now closed.
• Common stock continues to be listed and traded on the Nasdaq Global Market under the trading symbol "TELA".

Why it may matter This filing reports Item 8.01 (Other events), which covers events the company considers important enough to disclose that do not fall under other specified items. The filing states that Nasdaq has confirmed the Company has regained compliance with the minimum bid price requirement and that the listing matter is closed. A filing does not show why the insider traded or why the company acted.